FY2021
30 June 2021: development funding
The company reported no gold sales and closing cash of A$432,029; the auditor identified a material uncertainty related to going concern.
ASX: CTO · Five-year financial review
Citigold Corporation Limited (ASX: CTO) - Five-Year Financial Review FY2021-FY2025
Citigold is a Charters Towers gold development company. These annual-report figures allow comparison of statutory losses, cash use, financing and the group's financial position while distinguishing historical resource estimates from production.
Reading the tables: 0 (nil) is a supported zero. Other text distinguishes an amount included in another line, a non-applicable item, a separately unavailable component and an unresolved value. These are not interchangeable. Period-specific detail is labelled; complete year-by-year detail remains available.
FY2025 statutory loss
A$22.15m
Includes A$20m impairment
FY2025 operating cash flow
A$(0.72)m
Cash used in operations
Cash at 30 June 2025
A$0.45m
Consolidated closing balance
FY2025 equity
A$74.39m
After the impairment and annual loss
Five years in context
Citigold's Charters Towers project remained in a funding and development phase across the five years. The issuer reported no gold production in FY2025 and unchanged Mineral Resources and Ore Reserves. Historical cumulative production and the resource estimate should not be read as output during this review period.
Operating cash flow was negative in every year shown. Capital issues, borrowings and gold pre-sale proceeds supplied financing cash, while exploration, evaluation and development used investing cash. The FY2025 statutory loss is dominated by a separate A$20 million impairment; the cash-flow reconciliation adds back non-cash impairment, depreciation and amortisation.
The auditor's going-concern material-uncertainty statements and the gap between capitalised mining assets and market value are material context for reading the balance sheet. At 30 June 2025 the company reported A$2.80 million of negative working capital and a A$743,000 undrawn loan facility; neither is a substitute for cash on hand.
Events behind the numbers
FY2022
30 June 2022: current-liability pressure
Current assets of about A$0.38 million were below current liabilities of about A$1.91 million; management cited placements, loans and possible asset sales as funding sources.
FY2023
30 June 2023: funding and carrying-value scrutiny
The auditor identified going-concern uncertainty and an impairment indicator as the company's market capitalisation was below group net assets.
FY2024
30 June 2024: pre-sales and refinancing dependence
The company reported A$635,452 of gold pre-sale proceeds and no gold sales from mining operations; the auditor described reliance on refinancing through share placements and purchase plans.
FY2025
30 June 2025: impairment and liquidity
A$20 million impairment was recognised. Closing cash was A$449,425 and negative working capital A$2.80 million; the auditor retained a going-concern material-uncertainty paragraph.
FINANCIAL REVIEW / 01
Statutory performance
The A$20 million FY2025 impairment accounts for most of that year's A$22.15 million statutory loss. The statement's small FY2024 and FY2025 revenue amounts are accrual revenue, while customer cash receipts appear separately in the cash-flow statement.
Loss after tax (A$)
A$
(Loss)/Profit after tax from continuing operations
AI-generated presentation · values from Statutory consolidated profit or loss; no missing values plotted as zero.
Statutory consolidated profit or loss
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | Nil | Nil | Nil | 46,000 | 20,000 |
| Cost of Sales | Nil | Nil | Nil | -107,527 | -90,360 |
| Gross Profit / (Loss) | Nil | Nil | Nil | -61,527 | -70,360 |
| Other Income | 151,349 | 106,762 | 129,578 | 170,669 | 32,139 |
| Personnel benefits expense | -284,564 | -295,000 | -295,000 | -295,000 | -295,000 |
| Depreciation and amortisation expense | -86,014 | -73,566 | -58,608 | -34,617 | -27,667 |
| Finance costs | -127,621 | -210,819 | -415,414 | -362,460 | -530,076 |
| Consulting expense | -413,251 | -559,455 | -574,328 | -404,524 | -407,240 |
| Other expenses | -656,056 | -861,036 | -1,117,870 | -1,323,378 | -851,721 |
| Impairment expense | Not separately presented | Not separately presented | Not separately presented | Nil | -20,000,000 |
| (Loss)/Profit before income tax | -1,416,157 | -1,893,114 | -2,331,642 | -2,310,837 | -22,149,925 |
| Income tax expense | Nil | Nil | Nil | Nil | Nil |
| (Loss)/Profit after tax from continuing operations | -1,416,157 | -1,893,114 | -2,331,642 | -2,310,837 | -22,149,925 |
FY2025's A$20m impairment is separately stated. FY2024's dash is the FY2025 report comparative. Earlier statements have no separate impairment line.
Revenue in the profit or loss statement differs from cash receipts; these are distinct accrual and cash measures.
The first separately identified impairment line in the selected P&L evidence is the FY2024 nil comparative in the FY2025 report; FY2021–FY2023 are not assigned a nil amount from the absence of a separate line.
Basis and presentation notes (18)
- Revenue / FY2021 — Nil: Issuer statement shows a dash or nil for this line.
- Revenue / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Revenue / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Cost of Sales / FY2021 — Nil: Issuer statement shows a dash or nil for this line.
- Cost of Sales / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Cost of Sales / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Gross Profit / (Loss) / FY2021 — Nil: Issuer statement shows a dash or nil for this line.
- Gross Profit / (Loss) / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Gross Profit / (Loss) / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Impairment expense / FY2021 — Not separately presented: No separate impairment line is identified in the selected FY2021 statutory P&L extraction; the statutory result is retained. The FY2024 comparative has an explicit nil impairment line in the FY2025 statement (R002867), which is a distinct period.
- Impairment expense / FY2022 — Not separately presented: No separate impairment line is identified in the selected FY2022 statutory P&L extraction; the statutory result is retained. The FY2024 comparative has an explicit nil impairment line in the FY2025 statement (R002867), which is a distinct period.
- Impairment expense / FY2023 — Not separately presented: No separate impairment line is identified in the selected FY2023 statutory P&L extraction; the statutory result is retained. The FY2024 comparative has an explicit nil impairment line in the FY2025 statement (R002867), which is a distinct period.
- Impairment expense / FY2024 — Nil: FY2025 annual report comparative shows a dash for FY2024.
- Income tax expense / FY2021 — Nil: Issuer statement shows a dash or nil for this line.
- Income tax expense / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Income tax expense / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Income tax expense / FY2024 — Nil: Scale not stated; fully offset by deferred tax per Note 6
- Income tax expense / FY2025 — Nil: Scale not stated
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
Result attribution and comprehensive income
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss attributable to non-controlling interest | Nil | Nil | Nil | Nil | Nil |
| Loss attributable to members of the company | -1,416,157 | -1,893,114 | -2,331,642 | -2,310,837 | -22,149,925 |
| Total comprehensive income | -1,416,157 | -1,893,114 | -2,331,642 | -2,310,837 | -22,149,925 |
Basis and presentation notes (5)
- Loss attributable to non-controlling interest / FY2021 — Nil: Issuer statement shows a dash or nil for this line.
- Loss attributable to non-controlling interest / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Loss attributable to non-controlling interest / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Loss attributable to non-controlling interest / FY2024 — Nil: Scale not stated
- Loss attributable to non-controlling interest / FY2025 — Nil: Scale not stated
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
Earnings per share and share denominator
Mixed: cents per share; shares
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Basic and diluted EPScents per share | -0.0527 | -0.067 | -0.082 | -0.0789 | -0.7383 |
| Weighted average ordinary shares (basic and diluted)shares | 2,686,414,277 | 2,827,615,073 | 2,843,659,091 | 2,930,079,826 | 3,000,000,000 |
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
FINANCIAL REVIEW / 02
Financial position and funding obligations
Property, plant and equipment fell in FY2025 as the impairment was recognised. Current liabilities exceeded current assets at the latest balance date, and non-current borrowings increased over the five years. The reported liability and provision lines are retained separately.
Cash and non-current borrowings (A$)
$ (as reported)
Cash and cash equivalentsBorrowings (non-current)
AI-generated presentation · values from Consolidated financial position at 30 June; no missing values plotted as zero.
Consolidated financial position at 30 June
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents$ (as reported) | 432,029 | 224,953 | 219,634 | 221,070 | 449,425 |
| Trade and other receivables$ (as reported) | 130,965 | 157,590 | 161,247 | 167,284 | 47,478 |
| Total current assets$ (as reported) | 562,994 | 382,543 | 380,881 | 388,354 | 496,903 |
| Property, plant and equipment$ (as reported) | 109,931,407 | 110,638,724 | 111,451,427 | 112,459,460 | 93,426,449 |
| Other financial assets (non-current)$ (as reported) | 543,803 | 546,303 | 663,763 | 756,495 | 763,995 |
| Total non-current assets$ (as reported) | 110,475,210 | 111,185,027 | 112,115,190 | 113,215,955 | 94,190,444 |
| Total assets$ (as reported) | 111,038,204 | 111,567,570 | 112,496,071 | 113,604,309 | 94,687,347 |
| Trade and other payables (current)$ (as reported) | 2,444,534 | 1,912,568 | 1,662,012 | 1,844,130 | 3,298,597 |
| Total current liabilities$ (as reported) | 2,444,534 | 1,912,568 | 1,662,012 | 1,844,130 | 3,298,597 |
| Trade and other payables (non-current)$ (as reported) | 5,877,894 | 7,209,948 | 9,039,810 | 10,971,125 | 11,658,169 |
| Borrowings (non-current)$ (as reported) | 617,267 | 1,677,659 | 3,041,035 | 3,559,070 | 4,650,522 |
| Provisions (non-current)$ (as reported) | 483,706 | 483,706 | 601,167 | 693,899 | 693,899 |
| Total non-current liabilities$ (as reported) | 6,978,867 | 9,371,313 | 12,682,012 | 15,224,094 | 17,002,590 |
| Total liabilities$ (as reported) | 9,423,401 | 11,283,881 | 14,344,024 | 17,068,224 | 20,301,187 |
| Net assets$ (as reported) | 101,614,803 | 100,283,689 | 98,152,047 | 96,536,085 | 74,386,160 |
Each year uses its own annual-report current-year column. FY2022 borrowings are A$1,677,659 (borrowings row), not the identically valued FY2022 trade-payables pointer in the starting draft.
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
Non-current borrowings by counterparty
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Unsecured – unrelated parties$ (as reported) | 423,994 | 759,311 | 1,059,417 | 945,306 | 1,377,260 |
| Unsecured – related parties$ (as reported) | 193,273 | 231,218 | 255,070 | 279,959 | 293,686 |
| Secured – unrelated parties$ (as reported) | Nil | 687,130 | 1,726,548 | 2,333,805 | 2,979,576 |
| Total non-current borrowings$ (as reported) | 617,267 | 1,677,659 | 3,041,035 | 3,559,070 | 4,650,522 |
Basis and presentation notes (1)
- Secured – unrelated parties / FY2021 — Nil: FY2022 annual borrowings note comparative shows nil FY2021 secured unrelated-party loans.
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
FINANCIAL REVIEW / 03
Cash generation and capital spending
The group used cash in operations and exploration, evaluation and development in every period shown. Financing proceeds include share issues, loans and gold pre-sales; the latter are funding cash receipts, not current gold-sales revenue. The FY2025 reconciliation distinguishes the non-cash impairment add-back from operating cash payments.
Operating and investing cash flows (A$)
A$
Net cash (used in) / provided by operating activitiesNet cash (used in) / provided by investing activities
AI-generated presentation · values from Consolidated cash flows; no missing values plotted as zero.
Consolidated cash flows
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Receipts from customers | 150,016 | 4,126 | Nil | Nil | Nil |
| Interest received | 503 | Nil | Nil | Nil | Nil |
| Payments to suppliers and personnel | -1,472,677 | -1,581,305 | -1,870,122 | -1,084,464 | -715,873 |
| Interest and other costs of finance paid | -26,370 | -2,775 | Nil | Nil | -1,292 |
| Net cash (used in) / provided by operating activities | -1,348,528 | -1,579,954 | -1,870,122 | -1,084,464 | -717,165 |
| Exploration, Evaluation and Development | -567,645 | -201,872 | -209,697 | -316,552 | -372,180 |
| Payments for PPE | -4,000 | Nil | Nil | Nil | Nil |
| Security Deposits | Not separately presented | Not separately presented | Not separately presented | Not separately presented | -7,500 |
| Net cash (used in) / provided by investing activities | -571,645 | -201,872 | -209,697 | -316,552 | -379,680 |
| Proceeds from issues of equity securities | 2,001,417 | 562,000 | 200,000 | 694,875 | Nil |
| Proceeds from borrowings | 560,000 | 1,172,750 | 1,082,000 | 1,007,000 | 820,000 |
| Repayment of borrowings | -225,000 | -280,000 | -100,000 | -934,875 | -264,000 |
| Proceeds from pre-sales (gold) | Nil | 120,000 | 892,500 | 635,452 | 769,200 |
| Net cash provided by / (used in) financing activities | 2,336,417 | 1,574,750 | 2,074,500 | 1,402,452 | 1,325,200 |
| Net increase / (decrease) in cash and cash equivalents | 416,244 | -207,076 | -5,319 | 1,436 | 228,355 |
| Cash and cash equivalents at end of the financial year | 432,029 | 224,953 | 219,634 | 221,070 | 449,425 |
Payments for PPE are investing cash flows, separate from closing property, plant and equipment assets.
FY2024 security deposits are a blank comparative cell in the FY2025 statement, not a nil amount.
Security deposits were first shown as a separate FY2025 investing line in the selected schedules; the FY2024 comparative is blank. Earlier years are marked not separately presented rather than zero.
Basis and presentation notes (19)
- Receipts from customers / FY2023 — Nil: reported nil
- Receipts from customers / FY2024 — Nil: reported nil
- Receipts from customers / FY2025 — Nil: reported nil
- Interest received / FY2022 — Nil: Issuer statement shows a dash or nil for this line.
- Interest received / FY2023 — Nil: Issuer statement shows a dash or nil for this line.
- Interest received / FY2024 — Nil: Issuer statement shows a dash or nil for this line.
- Interest received / FY2025 — Nil: Issuer statement shows a dash or nil for this line.
- Interest and other costs of finance paid / FY2023 — Nil: reported nil
- Interest and other costs of finance paid / FY2024 — Nil: reported nil
- Payments for PPE / FY2022 — Nil: reported nil
- Payments for PPE / FY2023 — Nil: reported nil
- Payments for PPE / FY2024 — Nil: reported nil
- Payments for PPE / FY2025 — Nil: reported nil
- Security Deposits / FY2021 — Not separately presented: The selected FY2022 cash-flow schedule, including its FY2021 comparative, has no separately presented security deposit line. No zero is inferred from absence or a blank.
- Security Deposits / FY2022 — Not separately presented: The selected FY2022 cash-flow schedule, including its FY2021 comparative, has no separately presented security deposit line. No zero is inferred from absence or a blank.
- Security Deposits / FY2023 — Not separately presented: The selected FY2023 investing cash-flow extraction has no separately attributed security-deposit line; the investing subtotal is reported. No zero is inferred from absence or a blank.
- Security Deposits / FY2024 — Not separately presented: The FY2025 cash-flow schedule explicitly has a blank FY2024 comparative cell on the security-deposits line, while FY2025 reports an outflow. No zero is inferred from absence or a blank.
- Proceeds from issues of equity securities / FY2025 — Nil: reported nil
- Proceeds from pre-sales (gold) / FY2021 — Nil: reported nil (dash) per FY2022 comparative
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
Reconciliation of loss to operating cash flow
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| (Loss) / Profit for the year | -1,416,157 | -1,893,114 | -2,331,642 | -2,310,837 | -22,149,925 |
| Impairment, Depreciation and Amortisation (net of write-back on assets sold) | 86,014 | 73,566 | 58,608 | 34,617 | 20,027,667 |
| (Increase) / decrease in Trade and other receivables | -30,779 | 83,152 | Nil | 170,669 | 122,249 |
| (Increase) / decrease in inventories | Nil | Nil | Nil | Nil | Nil |
| (Decrease) / increase in trade, financing costs and other payables | 283,280 | 156,442 | 285,452 | 928,355 | 1,252,844 |
| Increase / (decrease) in Employee provisions | -270,886 | Nil | Included in combined line | Included in combined line | Included in combined line |
| Provision movement (employee-specific through FY2022; generic thereafter) | (270,886) | 0 (nil) | 117,460 | 92,732 | 30,000 |
| Net Cash (used in) / provided by operating activities (reconciled subtotal) | -1,348,528 | -1,579,954 | -1,870,122 | -1,084,464 | -717,165 |
FY2025 non-cash impairment, depreciation and amortisation net of write-back is the issuer's combined reconciliation line; it is not an additional cash cost.
Provision disclosure changes after FY2022. FY2021–FY2022 show an employee-provision adjustment; FY2023–FY2025 show a generic provision adjustment without an employee breakdown. The broad provision row repeats the FY2021–FY2022 employee line for comparison and must not be added to the employee row.
Basis and presentation notes (11)
- (Increase) / decrease in Trade and other receivables / FY2023 — Nil: reported nil
- (Increase) / decrease in inventories / FY2021 — Nil: reported nil
- (Increase) / decrease in inventories / FY2022 — Nil: reported nil
- (Increase) / decrease in inventories / FY2023 — Nil: reported nil
- (Increase) / decrease in inventories / FY2024 — Nil: reported nil
- (Increase) / decrease in inventories / FY2025 — Nil: reported nil
- Increase / (decrease) in Employee provisions / FY2022 — Nil: reported nil
- Increase / (decrease) in Employee provisions / FY2023 — Included in combined line: The FY2023 cash-flow reconciliation presents a generic provision adjustment (R001643) without a separate employee-provision component. The amount appears once in the provision row below; no employee-specific amount is inferred.
- Increase / (decrease) in Employee provisions / FY2024 — Included in combined line: The FY2024 cash-flow reconciliation presents a generic provision adjustment (R002305) without a separate employee-provision component. The amount appears once in the provision row below; no employee-specific amount is inferred.
- Increase / (decrease) in Employee provisions / FY2025 — Included in combined line: The FY2025 cash-flow reconciliation presents a generic provision adjustment (R002840) without a separate employee-provision component. The amount appears once in the provision row below; no employee-specific amount is inferred.
- Provision movement (employee-specific through FY2022; generic thereafter) / FY2022 — 0 (nil): FY2022 issuer-reported nil for 'Increase/(decrease) in Employee provisions' (R000976). This is the only separately presented provision adjustment in the FY2022 selected reconciliation; FY2023 comparative R001644 is blank, so the FY2022 current-year source governs. Repeated here for the broad series, not additive to the employee row.
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
FINANCIAL REVIEW / 04
Share capital and equity
Citigold did not declare dividends in the five annual periods. The share count reached three billion by 30 June 2024 and remained there at 30 June 2025; FY2025 equity declined with the statutory loss. No return of capital is inferred from a missing buy-back row.
Components of consolidated equity
A$
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Issued capitalAUD | 219,331,455 | 219,893,455 | 220,093,455 | 220,788,330 | 220,788,330 |
| Asset revaluation reserveAUD | 37,851,949 | 37,851,949 | 37,851,949 | 37,851,949 | 37,851,949 |
| Capital profits reserveAUD | 571,430 | 571,430 | 571,430 | 571,430 | 571,430 |
| Share-based payments reserveAUD | 834,163 | 834,163 | 834,163 | 834,163 | 834,163 |
| Accumulated lossesAUD | -156,985,079 | -158,878,193 | -161,209,835 | -163,520,672 | -185,670,597 |
| Equity attributable to owners of parentAUD | 101,603,918 | 100,272,804 | 98,141,162 | 96,525,200 | 74,375,275 |
| Non-controlling interestAUD | 10,885 | 10,885 | 10,885 | 10,885 | 10,885 |
| Total equityAUD | 101,614,803 | 100,283,689 | 98,152,047 | 96,536,085 | 74,386,160 |
The FY2025 accumulated-loss note differs by A$1 from the primary statement; the primary statement's A$(185,670,596) is used for the balance-sheet row, while this note row retains its original A$(185,670,597) value.
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
FINANCIAL REVIEW / 05
Charters Towers resource base
The resource and reserve figures are repeated estimates based on the 2020 Mineral Resources and Ore Reserves report. The FY2025 annual report says no production or infill drilling occurred during the year and that material assumptions remained unchanged. Probable reserves are included within indicated resources, so their ounces are not additive.
Mineral Resources and Ore Reserves disclosed in each annual report
Mixed: tonnes; g/t Au; ounces
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Inferred Mineral Resources – tonnestonnes | 32,000,000 | 32,000,000 | 32,000,000 | 32,000,000 | 32,000,000 |
| Inferred Mineral Resources – gradeg/t Au | 14 | 14 | 14 | 14 | 14 |
| Inferred Mineral Resources – cut-off gradeg/t Au | 3 | 3 | 3 | 3 | 3 |
| Inferred Mineral Resources – contained ouncescontained ounces | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 |
| Indicated Mineral Resources (incl. Probable Reserves) – tonnestonnes | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 | 3,200,000 |
| Indicated Mineral Resources (incl. Probable Reserves) – gradeg/t Au | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 |
| Indicated Mineral Resources (incl. Probable Reserves) – cut-off gradeg/t Au | 4 | 4 | 4 | 4 | 4 |
| Indicated Mineral Resources (incl. Probable Reserves) – contained ouncescontained ounces | 780,000 | 780,000 | 780,000 | 780,000 | 780,000 |
| Probable Ore Reserves – tonnestonnes | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 | 2,500,000 |
| Probable Ore Reserves – gradeg/t Au | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 |
| Probable Ore Reserves – cut-off gradeg/t Au | 4 | 4 | 4 | 4 | 4 |
| Probable Ore Reserves – contained ouncescontained ounces | 620,000 | 620,000 | 620,000 | 620,000 | 620,000 |
The FY2021–FY2025 reports repeat the 2020 Mineral Resources and Ore Reserves estimate. Indicated resources include probable reserves; they must not be added together.
These are resource and reserve estimates, not annual production or sales.
Source: Citigold annual reports FY2021–FY2025; current-year observations are preferred to later comparatives unless stated.
Reading the figures
- The FY2025 balance-sheet accumulated-loss line and the related equity note differ by A$1; both original observations are retained and labelled.
- Eight historical component cells are not separately presented in the selected annual statements. They are displayed as unavailable components, without imputing nil or zero; their source presentation is logged.
- The historical 2020 resource estimate is repeated in five annual reports; no annual production series is asserted.
Annual-report source registry
- Annual Report to ShareholdersCitigold Corporation Limited; year ended 2021-06-30; annual report dated 2021-08-20.
- Annual Report to ShareholdersCitigold Corporation Limited; year ended 2022-06-30; annual report dated 2022-08-24.
- Annual Report to ShareholdersCitigold Corporation Limited; year ended 2023-06-30; annual report dated 2023-09-27.
- Annual Report to ShareholdersCitigold Corporation Limited; year ended 2024-06-30; annual report dated 2024-09-30.
- Annual Report to ShareholdersCitigold Corporation Limited; year ended 2025-06-30; annual report dated 2025-09-29.
Prepared from the existing annual extraction datasets, supplemented only by selected same-company annual-report tables and saved row interpretations. No new raw-document extraction or web financial research was used for this test.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.